Clinical Pearls for the Management of HS
An expert in dermatological conditions discusses office-based procedures that can benefit patients with HS and shares clinical pearls for the management of the disorder.
Read More
Unmet Needs and Emerging Therapies in HS
Andrew Baker PA-C, MBA, reviews unmet needs for the clinical management of moderate-to-severe HS and shares insight on novel and emerging therapies in the pipeline.
Role of TNF-α Inhibitors in Moderate-to-Severe HS Treatment
A physician assistant expert in dermatological conditions comments on the use of biological therapy to manage moderate-to-severe HS in adults and adolescents and the long-term effectiveness of these agents.
Overview and Diagnosis of Hidradenitis Suppurativa (HS)
Andrew Baker PA-C, MBA, provides an overview of hidradenitis suppurativa (HS), including the pathogenesis, comorbidities, and diagnosis of this inflammatory disorder.